Provided By PR Newswire
Last update: Jan 6, 2024
NEW YORK, Jan. 6, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:NEO (8/28/2025, 3:08:04 PM)
7.105
+0.03 (+0.35%)
Find more stocks in the Stock Screener